title: Strategies to overcome hyperacute rejection of pig-to-human xenografts.
authors.affiliation: Austin Research Institute, Austin & Repatriation Medical Center, Heidelberg, Australia.
authors.forename: I F
authors.initials: IF
authors.lastname: McKenzie
authors.forename: N
authors.initials: N
authors.lastname: Osman
authors.forename: S
authors.initials: S
authors.lastname: Cohney
authors.forename: M S
authors.initials: MS
authors.lastname: Sandrin
mesh_terms: D000208:Acute Disease; D000818:Animals; D030801:Animals, Genetically Modified; D000910:Antibodies, Heterophile / Q000302:isolation & purification; D000915:Antibody Affinity; D015478:Antigens, Heterophile / Q000276:immunology*; D003169:Complement Inactivator Proteins; D004187:Disaccharides / Q000276:immunology*; D004546:Elapid Venoms / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D013552:Swine
chemical_list: D000910:Antibodies, Heterophile; D015478:Antigens, Heterophile; D003169:Complement Inactivator Proteins; D004187:Disaccharides; D004546:Elapid Venoms; C016310:cobra venom factor; C055075:galactosyl-(1-3)galactose